Literature DB >> 28295574

CD38 positively regulates postnatal development of astrocytes cell-autonomously and oligodendrocytes non-cell-autonomously.

Tsuyoshi Hattori1, Minoru Kaji1, Hiroshi Ishii1, Roboon Jureepon1, Mika Takarada-Iemata1, Hieu Minh Ta1, Thuong Manh Le1, Ayumu Konno2, Hirokazu Hirai2, Yoshitake Shiraishi3, Noriyuki Ozaki3, Yasuhiko Yamamoto4, Hiroshi Okamoto4,5, Shigeru Yokoyama6, Haruhiro Higashida6, Yasuko Kitao1, Osamu Hori1.   

Abstract

Glial development is critical for the function of the central nervous system. CD38 is a multifunctional molecule with ADP-ribosyl cyclase activity. While critical roles of CD38 in the adult brain such as oxytocin release and social behavior have been reported, those in the developing brain remain largely unknown. Here we demonstrate that deletion of Cd38 leads to impaired development of astrocytes and oligodendrocytes in mice. CD38 is highly expressed in the developing brains between postnatal day 14 (P14) and day 28 (P28). In situ hybridization and FACS analysis revealed that CD38 is expressed predominantly in astrocytes in these periods. Analyses of the cortex of Cd38 knockout (Cd38-/- ) mice revealed delayed development of astrocytes and subsequently delayed differentiation of oligodendrocytes (OLs) at postnatal stages. In vitro experiments using primary OL cultures, mixed glial cultures, and astrocytic conditioned medium showed that astrocytic CD38 regulates the development of astrocytes in a cell-autonomous manner and the differentiation of OLs in a non-cell-autonomous manner. Further experiments revealed that connexin43 (Cx43) in astrocytes plays a promotive role for CD38-mediated OL differentiation. Finally, increased levels of NAD+ , caused by CD38 deficiency, are likely to be responsible for the suppression of astrocytic Cx43 expression and OL differentiation. Our data indicate that CD38 is a positive regulator of astrocyte and OL development.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  NAD; autism; connexin 43; cortex; hemichannel; myelin

Mesh:

Substances:

Year:  2017        PMID: 28295574     DOI: 10.1002/glia.23139

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  19 in total

1.  Effects of O-GlcNAcylation on functional mitochondrial transfer from astrocytes.

Authors:  Ji-Hyun Park; Yoshihiko Nakamura; Wenlu Li; Gen Hamanaka; Ken Arai; Eng H Lo; Kazuhide Hayakawa
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-05       Impact factor: 6.200

2.  A multiscale analysis in CD38-/- mice unveils major prefrontal cortex dysfunctions.

Authors:  Lora L Martucci; Muriel Amar; Remi Chaussenot; Gabriel Benet; Oscar Bauer; Antoine de Zélicourt; Anne Nosjean; Jean-Marie Launay; Jacques Callebert; Catherine Sebrié; Antony Galione; Jean-Marc Edeline; Sabine de la Porte; Philippe Fossier; Sylvie Granon; Cyrille Vaillend; José-Manuel Cancela
Journal:  FASEB J       Date:  2019-03-07       Impact factor: 5.191

3.  Critical Role of Astrocyte NAD+ Glycohydrolase in Myelin Injury and Regeneration.

Authors:  Monica R Langley; Chan-Il Choi; Thais R Peclat; Yong Guo; Whitney L Simon; Hyesook Yoon; Laurel Kleppe; Claudia F Lucchinetti; Claudia C S Chini; Eduardo N Chini; Isobel A Scarisbrick
Journal:  J Neurosci       Date:  2021-09-07       Impact factor: 6.167

Review 4.  Resolving the topological enigma in Ca2+ signaling by cyclic ADP-ribose and NAADP.

Authors:  Hon Cheung Lee; Yong Juan Zhao
Journal:  J Biol Chem       Date:  2019-10-31       Impact factor: 5.157

Review 5.  CD38: A Potential Therapeutic Target in Cardiovascular Disease.

Authors:  Wanyun Zuo; Na Liu; Yunhong Zeng; Yaozhong Liu; Biao Li; Keke Wu; Yunbin Xiao; Qiming Liu
Journal:  Cardiovasc Drugs Ther       Date:  2021-08       Impact factor: 3.727

6.  Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD.

Authors:  Jureepon Roboon; Tsuyoshi Hattori; Hiroshi Ishii; Mika Takarada-Iemata; Dinh Thi Nguyen; Collin D Heer; Denis O'Meally; Charles Brenner; Yasuhiko Yamamoto; Hiroshi Okamoto; Haruhiro Higashida; Osamu Hori
Journal:  J Neurochem       Date:  2021-05-09       Impact factor: 5.546

7.  Expression and Regulatory Network Analysis of miR-140-3p, a New Potential Serum Biomarker for Autism Spectrum Disorder.

Authors:  Matilde Cirnigliaro; Cristina Barbagallo; Mariangela Gulisano; Carla N Domini; Rita Barone; Davide Barbagallo; Marco Ragusa; Cinzia Di Pietro; Renata Rizzo; Michele Purrello
Journal:  Front Mol Neurosci       Date:  2017-08-10       Impact factor: 5.639

8.  Inhibition of CD38/Cyclic ADP-ribose Pathway Protects Rats against Ropivacaine-induced Convulsion.

Authors:  Yu Zou; Xin He; Qian-Yi Peng; Qu-Lian Guo
Journal:  Chin Med J (Engl)       Date:  2017-10-05       Impact factor: 2.628

Review 9.  CD38/cADPR Signaling Pathway in Airway Disease: Regulatory Mechanisms.

Authors:  Deepak A Deshpande; Alonso G P Guedes; Richard Graeff; Soner Dogan; Subbaya Subramanian; Timothy F Walseth; Mathur S Kannan
Journal:  Mediators Inflamm       Date:  2018-02-07       Impact factor: 4.711

10.  Behavioral Changes in Mice Lacking Interleukin-33.

Authors:  Eisuke Dohi; Eric Y Choi; Indigo V L Rose; Akiho S Murata; Sharon Chow; Minae Niwa; Shin-Ichi Kano
Journal:  eNeuro       Date:  2017-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.